After Harvard resigned, students and doctors thought about medical school rankings.

Published Date: 22 Apr 2023

The US News and World Report rankings, once the benchmark by which students evaluated medical schools, have recently begun to lose some of their sway. The value of a school can be evaluated in various ways, according to medical students.

Read Full News

Latest News

Time to Rethink Early Morning In-Hospital Blood Draws?

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing.

Liver Enzyme Guides Prognosis in CKD Patients on Dialysis

Among patients with CKD, serum total ALP and its liver, bone, and intestinal fractions increase with disease severity, and liver ALP is associated with mortality in those undergoing haemodialysis.

COVID Shots in Pregnancy Protect Infants’ First 6 Months

The research adds important evidence for clinicians counseling pregnant patients.

Medical Accuracy of 'The Pitt'

The cast and creators of HBO Max's 'The Pitt' explain how they get the medicine right, and why it matters.

‘I HATE YOU’ and Other Things People Say to Their Doctors

Patient rudeness, in-person or on the portal, is more common than ever, and data now show it’s taking a toll on quality care.

Barzolvolimab Shows Persistent Benefits for CSU

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

Delaying in-hospital blood draws by just 2 hours helped sleep quality and quantity, researchers find. Now, some hospitals are considering a change to traditional timing.

Among patients with CKD, serum total ALP and its liver, bone, and intestinal fractions increase with disease severity, and liver ALP is associated with mortality in those undergoing haemodialysis.

The research adds important evidence for clinicians counseling pregnant patients.

The cast and creators of HBO Max's 'The Pitt' explain how they get the medicine right, and why it matters.

Patient rudeness, in-person or on the portal, is more common than ever, and data now show it’s taking a toll on quality care.

Patients maintain their improvements off treatment, even after clearance of barzolvolimab, investigators report.

News All Time

IgAn Diagnostic and Therapeutic Strategies

Explore how updated KDIGO IgAN guidelines, earlier biopsy driven risk stratification, and new targeted therapies (budesonide, sparsentan, complement/APRIL inhibitors) are reshaping long term outcomes.

Change Healthcare Breach Still Affecting Docs, Hospitals

Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024.

Peanut Introduction Kits Encourage Earlier Peanut Feeding

Peanut kits given in pediatric clinics were linked to a threefold increase in caregivers introducing the legume 2 months later.

Which Allergens Trigger Contact Dermatitis in HCPs?

Occupational contact dermatitis affects North American healthcare workers and is commonly linked to glove rubber accelerators, surfactants, and preservatives, a retrospective study finds.

Panel Endorses Early Introduction of Food Allergens

A panel convened by the FDA also called for more attention to skin sensitization.

Multitargeted Therapy in Kids With IMIDs: Is It Effective?

In kids with immune-mediated inflammatory diseases, multitargeted therapy may benefit some, with over half achieving remission, although more than 1 in 4 require hospitalization for infections.

Being Honest About Uncertainty Fosters Trust

Acknowledging uncertainty about the limits of scientific research can foster trust in public health messaging and improve overall science literacy.

Depemokimab Shows Promise in Type 2 Asthma With Nasal Polyps

An asthma medication improves asthma control, respiratory quality of life, and upper airway symptoms in patients with chronic rhinosinusitis with nasal polyps.

How to Build Trust When Patients Believe Misinformation

Successful communication is built on trust.

New ECDC Panel to Develop Adult RSV Vaccination Guidance

The ECDC, the infectious diseases watchdog, has asked for scientists to join its new panel on RSV as Europe begins to vaccinate its most vulnerable adults.

South Carolina Reports Three New Measles Cases, Outbreak Total Rises to 996

South Carolina health officials reported three new measles cases on ⁠Friday, pushing the total number of infections linked to the outbreak ⁠to 996, the state health...

Survey Reveals Gaps in Pediatric EMS Readiness in the US

Out-of-hospital readiness in pediatric emergency medical service agencies in the US is modest; gaps remain in family-centered care, quality improvement, and coordination of care.

Can Beta-Lactam Loading Help Tackle Resistant Klebsiella?

Loading dose regimen of beta-lactam may speed early bacterial clearance and improve clinical stability in non-ICU patients with resistant K pneumoniae bloodstream infections, a real-world study shows.

Enhanced-Delivery Chamber May Reduce Wheezing in Kids

A valved holding chamber with high drug delivery performance may reduce wheezing severity and hospitalizations more effectively than a device with lower delivery in young children, a trial shows.

Roflumilast Effective, Safe for AD in Children Over 56 weeks

Roflumilast cream 0.05% provides durable efficacy and is well-tolerated for up to 56 weeks in children aged 2-5 years with mild-to-moderate atopic dermatitis, a study finds.

Omalizumab Enables Safe Allergenic Food Introduction in Kids

Omalizumab treatment allows most children with immunoglobulin E-mediated food allergy to complete oral food challenges and undergo dietary introduction.

Recommended News For You

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

More evidence links physical activity with improved cancer survival

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Coffee and tea linked to lower head and neck cancer risk

Breast cancer: A new target to eliminate dormant cells before they wake

Recommended Articles For You

Case Study: Artificial Intelligence in Early Cancer Detection 

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Who Bears the Cost of "Forever Chemical" Cleanup?

2.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

3.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

4.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

5.

There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.

1.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

2.

How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?

3.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

4.

The Importance of Balanced Potassium Levels in Maintaining Good Health

5.

Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot